The $518M deal for Bioventus to buy Misonix is now complete

DURHAM - Bioventus Inc. (Nasdaq: BVS) announced on Friday that the company has completed its acquisition of Misonix, Inc. in a cash and stock transaction worth

Related Keywords

Israel ,Stavros Vizirgianakis ,Patrick Beyer ,Regulatory Affairs ,Cartiheal Ltd ,Misonix Inc ,Bioventus Inc ,Nasdaq ,Bioventus Board ,Ken Reali ,Sharon Klugewicz ,Senior Vice President ,